Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses and disease outcome

Nestle Nutrition Workshop Series: Pediatric Program

Volumn 61, Issue , 2008, Pages 145-177

  Ogra, P ^a   Welliver Sr , R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); MAMMALIA; VERMES;

DENDRITIC CELL; ENVIRONMENT; FEMALE; GASTROINTESTINAL TRACT; HUMAN; IMMUNOLOGY; INFANT; INFANT NUTRITION; INNATE IMMUNITY; INTESTINE MUCOSA; LYMPHOID TISSUE; MALE; MICROBIOLOGY; MUCOSAL IMMUNITY; NEWBORN; PEYER PATCH; REVIEW; T LYMPHOCYTE;

DENDRITIC CELLS; ENVIRONMENT; FEMALE; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; INFANT; INFANT NUTRITION PHYSIOLOGY; INFANT, NEWBORN; INTESTINAL MUCOSA; LYMPHOID TISSUE; MALE; PEYER'S PATCHES; T-LYMPHOCYTES;

EID: 42449134560     PISSN: 16616677     EISSN: 16623878     Source Type: Book Series    
DOI: 10.1159/000113492     Document Type: Conference Paper

References (130)

1. Crichton M: Prey. New York, Harper Collins, 2002, pp 250-251.
2. Rhee SJ, Ogra P, Walker WA: Mucosal immunity; in Baker SS, Baker RD, David AM (eds): Pediatric Nutrition Support. Sudbury, Bartlett, 2006, pp 29-43.
3. Mashimo H, Wu DC, Podolsky DK, Fishman MC: Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:262-265.
4. White SH, Wimley SH, Selsted ME: Structure, function, and membrane integration of defensins. Curr Opin Struct BIol 1995;5:521-527.
5. Ganz T: Defensins and host defense. Science 1999;45:911-915.
6. Medzhitov R, Janeway CA Jr: Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997;9:4-9.
7. Fearon DT, Locksley RM: The instructive role of innate immunity in the acquired immune response. Science 1996;272:50-53.
8. Janeway CA Jr: Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Har Symp Quant Biol 1989;54:1-13.
9. Medzhitov R, Janeway C Jr: Innate immunity. N Engl J Med 2000;343:338-344.
10. Hashimoto C, Hudson KL, Anderson KV: The Toll gene of Drosophila, required for dorsalventral embryonic polarity, appears to encode a transmembrane protein. Cell 1999;52:269-279.
11. Rock FL, Hardiman G, Timans JC, et al: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998;95:588-593.
12. Schnare M, Rollinghoff M, Qureshi S: Toll-like receptors: sentinels of host defence against bacterial infection. Int Arch Allergy Immunol 2006;139:75-85.
13. Takeda K: Evolution and integration of innate immune recognition systems: the Toll-like receptors. J Endotoxin Res 2005;11:51-55.
14. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003;21:335-376.
15. Gewirtz AT, Navas TA, Lyons S, et al: Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001;167:1882-1885.
16. Andersen JM, Al-Khairy D, Ingalls RR: Innate immunity at the mucosal surface: role of tolllike receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol Reprod 2006;74:824-831.
17. Cook DN, Pisetsky DS, Schwartz DA: Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004;5:975-979.
18. Yang IA, Barton SJ, Rorke S, et al: Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun 2004;5:41-45.
19. Mezhitov R, Preston-Hurlburt P, Janeway CA: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
20. Liu YJ: IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005;23:275-306.
21. Krug A, Rothenfusser S, Hornung V, et al: Identification of CpG oligonucleotide sequences with high induction of IFN alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 2001;31:2154-2163.
22. Girardin SE, Boneca IG, Carneiro LA, et al: Nod1 detects a unique neuropeptide from gram-negative bacterial peptidoglycan. Science 2003;300:1584-1587.
23. Steinman RM, Hemmi H: Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006;311:17-58.
24. Chen CC, Louie S, McCormick BA, et al: Helminth-primed dendritic cells alter the host response to enteric bacterial infection. J Immunol 2006;176:472-483.
25. Hitotsumatsu O, Hamada H, Naganuma M, et al: Identification and characterization of novel gut-associated lymphoid tissues in rat small intestine. J Gastroenterol 2005;40:956-963.
26. Ivanov II, Diehl GE, Littman DR: Lymphoid tissue inducer cells in intestinal immunity. Curr Top Microbiol Immunol 2006;308:59-82.
27. Spencer J, Finn T, Isaacson PG: Gut associated lymphoid tissue: a morphological and immunocytochemical study of the human appendix. Gut 1985;26:672-679.
28. Golby S, Hackett M, Boursier L, et al: B cell development and proliferation of mature B cells in human fetal intestine. J Leukoc Biol 2002;72:279-284.
29. Fagarasan S, Kinoshita K, Muramatsu M, et al: In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 2001;413:639-643.
30. MacDonald TT, Spencer J: Ontogeny of the gut-associated lymphoid system in man. Acta Paediatr Suppl 1994;83:3-5.
31. Cerf-Bensussan N, Guy-Grand D: Intestinal intraepithelial lymphocytes. Gastroenterol Clin North Am 1991;20:549-576.
32. Maheshwari A, Zemlin M: Ontogeny of the intestinal immune system. Haematol Rep 2006;2:18-26.
33. Mellander L, Carlsson B, Hanson LA: Appearance of secretory IgM and IgA antibodies to Escherichia coli in saliva during early infancy and childhood. J Pediatr 1984;104:564-568.
34. Hayes JA, Adamson-Macedo EN, Perera S, Anderson J: Detection of secretory immunoglobulin A (SIgA) in saliva of ventilated and non-ventilated preterm neonates. Neuroendocrinol Lett 1999;20:109-113.
35. Fitzsimmons SP, Evans MK, Pearce CL, et al: Immunoglobulin A subclasses in infants' saliva and in saliva and milk from their mothers. J Pediatr 1994;124:566-573.
36. Wines BD, Hogarth PM: IgA receptors in health and disease. Tissue Antigens 2006;68:103-114.
37. Febervari Z, Sakaguchi S: CD4+ tregs and immune control. J Clin Invest 2004;114:1209-1217.
38. Cohen IR, Quintana FJ, Mimran A: Tregs in T cell vaccination: exploring the regulation of regulation. J Clin Invest 2004;114:1227-1232.
39. Jiang H, Chess L: An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 2004;114:1193-1208.
40. Holt PG: Functionally mature virus-specific CD8+ T memory cells in gongenitally infected newborns: proof of principle for neonatal vaccination? J Clin Invest 2003;111:1645-1647.
41. Iwakura Y, Ishigame H: The IL-23/IL-17 axis in inflammation. J Clin Invest 2006;116:1218-1222.
42. Lewis DB, Wilson CB: Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection; in Remington J, Klein J, Wilson C, Baker C (eds): Infectious Diseases of the Fetus and Newborn Infant, ed 6. Philadelphia, Elsevier-Saunders, 2006, pp 87-210.
43. Holt PG: Postnatal maturation of immune competence during infancy and early childhood. Pediatr Allergy Immunol 1995;6:59-70.
44. Holt PG, Jones CA: The development of the immune system during pregnancy and early childhood. Allergy 2000;55:688-697.
45. Holt PG, Clough JB, Holt BJ, et al: Genetic 'risk' for atopy is associated with delayed postnatal maturation of T-cell competence. Clin Exp Allergy 1992;22:1093-1099.
46. Callahan GN: Eating dirt. Emerging Infect Dis 2003;9:1016-1021.
47. Krishnamani R, Mahaney WC: Geophagy among primates: adaptive significance and ecological consequences. Anim Behav 2002;59:899-915.
48. Centers for Disease Control and Prevention: Racoon roundworm encephalitis - Chicago, Illinois, and Los Angeles, California, 2000. MMWR 2002;50:1153-1155.
49. Torsvik V, Salte K, Sorheim R, Goksoyr J: Comparison of phenotypic diversity and DNA heterogeneity in population of soil bacteria. Appl Environ Microbiol 1990;56:776-781.
50. Kent A, Triplett EW: Microbial communities and their interactions in soil and rhizosphere ecosystem. Annu Rev Microbiol 2002;56:211-236.
51. Margulis L, Sagan D, Thomas L: Microcosmos: Four Billion Years of Evolution from Our Microbial Ancestors. Berkeley, University of California Press, 1997.
52. Tannock GW: Normal Microflora. London, Chapman & Hall, 1995, pp 1-60.
53. Stark PL, Lee A: The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol 1982;15:189-203.
54. Savage DC: Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1997;31:107-133.
55. Ogra PL, Rassin DK, Garofalo RP: Human milk; in Remington J, Klein J, Wilson C, Baker C (eds): Infectious Diseases of the Fetus and Newborn Infant, ed 6. Philadelphia, Elsevier-Saunders, 2006, pp 211-243.
56. Neish AS, Gewirtz AT, Zeng H, et al: Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000;289:1560-1563.
57. Hooper LV, Gordon J: Commensal host-bacterial relationships in the gut. Science 2001;292:1115-1118.
58. Sudo N, Sawanura S-A, Tanaka K, et al: The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739-1745.
59. Adlerberth I, Hansson LA, Wold AE: The ontogeny of the intestinal flora; in Sanderson IR, Walker WA (eds): Development of the Gastrointestinal Tract. Hamilton, Decker, 1999, pp 279-292.
60. Bry L, Falk PG, Midtvedt T, Gordon JI: A model of host-microbial interactions in an open mammalian ecosystem. Science 1996;273:1380-1383.
61. Kolenbrander PE: Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol 2000;54:413-437.
62. Adlerberth I, Lindberg E, Aberg N, et al: Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle? Pediatr Res 2006;59:96-101.
63. Bach JF: The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-920.
64. Kamradt T, Göggel R, Erb KJ: Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol 2005;26:260-267.
65. Trujillo C, Erb KJ: Inhibition of allergic disorders by infection with bacteria or the exposure to bacterial products. Int J Med Microbiol 2003;293:123-131.
66. Marks GB, Ng K, Zhou J, et al: The effect of neonatal BCG vaccination on atopy and asthma at age 7 to14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Clin Immunol 2003;111:541-549.
67. da Cunha SS, Cruz AA, Dourado I, et al: Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCG. Allergy 2004;59:857-862.
68. Adams VC, Hunt JR, Martinelli R, et al: Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice. Eur J Immunol 2004;34:631-638.
69. Arkwright PD, David TJ: Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages. Br J Dermatol 2003;149:1029-1034.
70. Shirtcliffe PM, Easthope SE, Weatherall M, Beasley R: Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guerin in adult asthma. Clin Exp Allergy 2004;34:207-212.
71. Isolauri E, Salminen S: Probiotics, gut inflammation and barrier function. Gastroenterol Clin North Am 2005;34:437-450.
72. Helin T, Haahtela S, Haahtela T: No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 2002;57:243-246.
73. Herz U, Lacy P, Renz H, Erb K: The influence of infections on the development and severity of allergic disorders. Curr Opin Immunol 2000;12:632-640.
74. Maizels RM, Yazdanbakhsh M: Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003;3:733-744.
75. van den Biggelaar AH, Rodrigues LC, van Ree R, et al: Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese school-children. J Infect Dis 2004;189:892-900.
76. Wang CC, Nolan TJ, Schad GA, Abraham D: Infection of mice with the helminth Strongyloides stercoralis suppresses pulmonary allergic responses to ovalbumin. Clin Exp Allergy 2001;31:495-503.
77. Wohlleben G, Trujillo C, Muller J, et al: helminth infection modulates the development of allergen-induced airway inflammation. Int Immunol 2004;16:585-596.
78. Negrao-Correa D, Silveira MR, Borges CM, et al: Changes in pulmonary function and parasite burden in rats infected with Strongyloides venezuelensis concomitant with induction of allergic airway inflammation. Infect Immun 2003;71:2607-2614.
79. Bashir ME, Andersen P, Fuss IJ, et al: An enteric helminth infection protects against an allergic response to dietary antigen. J Immunol 2002;169:3284-3292.
80. Matricardi PM, Rosmini F, Riondino S, et al: Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ 2000;320:412-417.
81. Wohlleben G, Muller J, Tatsch U, et al: Influenza A virus infection inhibits the efficient recruitment of Th2 cells into the airwaays and the development of airway eosinophilia. J Immunnol 2003;170:4601-4611.
82. Marsland BJ, Nembrini C, Schmitz N, et al: Bystander suppression of allergic airway inflammation by lung resident memory CD8+ T cells. Proc Natl Acad Sci USA 2004;101:6116-6121.
83. Walzl G, Tafuro S, Moss P, et al: Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J Exp Med 2000;192:1317-1326.
84. Griffiths EA, Duffy LC, Schanbacher FL, et al: In vivo effects of Bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci 2004;49:579-589.
85. Duffy LC, Sporn S, Griffiths E, et al: Lactobacilli and bifidobacteria; in Coates PM, Blackman M, Cragg GM, et al (eds): Encyclopedia of Dietary Supplements. New York, Marcel Dekker, 2005, pp 381-389.
86. Madsen K, Cornish A, Soper P, et al: Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001;121:580-591.
87. Freihorst J, Piedra PA, Okamoto Y, Ogra PL: Effect of respiratory syncytial virus infection on the uptake of and immune response to other inhaled antigens. Proc Soc Exp Biol Med 1988;188:191-197.
88. Leibovitz E, Freihorst J, Piedra PA, Ogra PL: Modulation of systemic and mucosal immune responses to inhaled ragweed antigen in experimentally induced infection with respiratory syncytial virus implication in virally induced allergy. Int Archs Allergy Appl Immunol 1988;86:112-116.
89. Okamoto Y, Freihorst J, Ogra, PL: Maternal determinants of neonatal immune response to ovalbumin: effect of breast feeding on development of anti-ovalbumin antibody in the neonate. Int Arch Allergy Appl Immunol 1989;89:83-89.
90. Welliver RC, Ogra PL: Immunology of respiratory viral infections. Annu Rev Med 1988;39:147-162.
91. Williams JV, Crowe JE Jr, Enriquez R, et al: Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect Dis 2005;192:1149-1153.
92. Lieberman D, Lieberman D, Printz S, et al: Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med 2003;167:406-410.
93. Ennis DP, Cassidy JP, Mahon BP: Prior Bordetella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma. Clin Exp Allergy 2004;34:1488-1497.
94. Hardy RD, Jafri HS, Olsen K, et al: Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease. Infect Immun 2002;70:649-654.
95. Blasi F: Atypical pathogens and respiratory tract infections. Eur Respir J 2004;24:171-181.
96. Demirci M, Yildirim M, Aridogan BC, et al: Tissue parasites in patients with chronic urticaria. J Dermatol 2003;30:777-781.
97. Kamradt T, Mitchison NA: Tolerance and autoimmunity. N Engl J Med 2001;344:655-664.
98. Qin HY, Sadelain MW, Hitchon C, et al: Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol 1993;150:2072-2080.
99. Zaccone P, Raine T, Sidobre S, et al: Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. Curr J Immunol 2004;34:3246-3256.
100. Zaccone P, Fehervari Z, Jones FM, Sidobre S, Kronenberg M, Dunne DW, Cooke A: Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003;33:1439-1449.
101. Loftus EV Jr: Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-1517.
102. Ponsonby AL, van der Mei I, Dwyer T, et al: Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA 2005;293:463-469.
103. Sharif S, Arreaza GA, Zucker P, et al: Activation of natural killer T cells by alpha-galactosyl-ceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001;7:1057-1062.
104. Madsen KL, Doyle JS, Jewell LD, et al: Lactobacillis species prevents colitis in interleukin 10 gene deficient mice. Gastroenterology 1999;116:1107-1114.
105. Elliott DE, Setiawan T, Metwali A, et al: Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 2004;34:2690-2698.
106. Gionchetti P, Rizzello F, Helwig U, et al: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003;124:1202-1209.
107. Summers RW, Elliott DE, Urban JF Jr, et al: Trichuris suis therapy in Crohn's disease. Gut 2005;54:87-90.
108. Summers RW, Elliott DE, Qadir K, et al: Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 2003;98:2034-2041.
109. Lahita RG, Chiorazzi N, Reeves WH (eds): Textbook of the Autoimmune Diseases. Philadelphia, Lippincott, Williams & Wilkins, 2000.
110. Fourneau JM, Back JM, van Endert PM, Bach JF: The elusive case for a role of mimicry in autoimmune diseases. Mol Immunol 2004;40:1095-1102.
111. Schattner A, Rager-Zisman B: Virus-induced autoimmunity. Rev Infect Dis 1990;12:204-222.
112. Benoist C, Mathis D: Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2001;2:797-801.
113. Simpson JL, Wood LG, Gibson PG: Inflammatory mediators in exhaled breath, induced sputum and saliva. Clin Exp Allergy 2005;35:1180-1185.
114. Hashimoto K, Graham BS, Ho SB, et al: respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. Am J Respir Crit Care Med 2004;170:306-312.
115. John AE, Berlin AA, Lukacs NW: Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation. Eur J Immunol 2003;33:1677-1685.
116. Welliver TP, Garofalo RP, Hintz KH, et al: Severe human respiratory syncytial virus and influenza virus lower respiratory tract illness is characterized by the absence of pulmonary cytotoxic T-lymphocyte responses. J Infect Dis 2007;195:1126-1136.
117. Sayers I, Sevem W, Scanga CB, et al: Suppression of allergic airway disease using mycobacterial lipoglycans. J Allergy Clin Immunol 2004;114:302-309.
118. Iwasaki A, Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-995.
119. Geginat J, Lanzavecchia A, Sallusto F: Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4+ T cells. J Exp Med 2001;194:1711-1719.
120. Brennan FM, Hayes AL, Ciesielski CJ, et al: Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor κB pathways in tumor necrosis factor x production in rheumatoid arthritis. Arthritis Rheum 2002;46:31-41.
121. Faden H, Stanievich J, Brodsky L, et al: Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J 1990;9:623-626.
122. Faden H, Duffy L, Wasielewski R, et al: Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J Infect Dis 1997;175:1440-1445.
123. Faden H: The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr 2001;160:407-413.
124. Rayco-Solon P, Moore SE, Fulford AJ, Prentice AM: Fifty-year mortality trends in three rural African villages. Trop Med Int Health 2004;9:1151-1160.
125. Moore SE, Goldblatt D, Bates CJ, Prentice AM: Impact of nutritional status on antibody responses to different vaccines in undernourished Gambian children. Acta Paediatr 1002;92:170-176.
126. Moore SE, Jalil F, Ashraf F, et al: Birth weight predicts response to vaccination in adults born in an urban slum in Lahore, Pakistan. Am J Clin Nutr 2004;80:453-459.
127. Weinstock JV: Helminths and mucosal immune modulation. Ann NY Acad Sci 2006;1072:356-364.
128. van Duin D, Medzhitov R, Shaw AC: Triggering TLR signaling in vaccination. Trends Immunol 2006;27:49-55.
129. Strachan DP: Hay fever, hygiene, and household size. BMJ 1989;299:1259-1260.
130. Gerrard JW, Geddes CA, Reggin PL, et al: Serum IgE levels in white and Metis communities in Saskatchewan. Ann Allergy 1976;37:91-100.